An Effective Oral Drug Delivery Route for Pharmacokinetic Complications: Spirulina Lipid Nanotechnology System
Advanced Science · 2025-11 · 12 (44)
DOI: 10.1002/advs.202509731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.09.2025. Verfasst von Jiahui Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, P. R. China. Hauptthemen laut MEDLINE: Spirulina, Drug Delivery Systems, Irritable Bowel Syndrome, Nanotechnology. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Binjiang Institute of Zhejiang University, Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang.
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder characterized by mental manifestations, abdominal pain, and alterations in defecation habits. The incidence rate in some areas even exceeds 20%. Secondary to chronic, recurrent gastrointestinal motility dysfunction, for patients with IBS, upon oral administration of drugs, the fluctuation of bioavailability is typically far more significant than that of healthy individuals. Nevertheless, at present, few studies have put forward targeted drug delivery systems addressing this aspect. In this study, an oral spirulina nanotechnology System (SP@TIIAn) is developed that integrates tanshinone IIA liposome with spirulina for enhanced IBS treatment. Owing to the passive targeting of intestinal villi and enhanced adhesion by spirulina and nanoparticles, it is discovered that, in contrast to enteric‐coated capsules, this system is more beneficial for guaranteeing the pharmacokinetic stability of IBS. SP@TIIAn effectively treats multiple gut‐brain symptoms of IBS, contributing to providing new alternatives for the development of clinical medications for IBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, P. R. China.
- Institute of Translational Medicine, Zhejiang University, Hangzhou, 310029, P. R. China.
- Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University, Haining, 314400, P. R. China.
- Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Zhejiang University, Hangzhou, 310053, P. R. China.
- Zhejiang University-Ordos City Etuoke Banner Joint Research Center, Zhejiang University, Haining, 314400.
ORCID-Profile: Min Zhou
Förderung
- National Key R&D Program of China
- Binjiang Institute of Zhejiang University
- Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang
- Natural Science Foundation of Shandong Province
- National Key Research and Development Program of China
Zitieren
APA
Ye, J., Wu, X., Liu, J., Guo, Y., Ji, C., Wang, Z., Yang, D., & Zhou, M. (2025). An Effective Oral Drug Delivery Route for Pharmacokinetic Complications: Spirulina Lipid Nanotechnology System. Advanced Science, 12(44). https://doi.org/10.1002/advs.202509731
Vancouver
Ye J, Wu X, Liu J, Guo Y, Ji C, Wang Z, et al. An Effective Oral Drug Delivery Route for Pharmacokinetic Complications: Spirulina Lipid Nanotechnology System. Advanced Science. 2025;12(44). doi:10.1002/advs.202509731
BibTeX
@article{Ye2025,
author = {Ye, Jiahui and Wu, Xinyi and Liu, Jin and Guo, Yongmi and Ji, Chong and Wang, Zhouyue and Yang, Di and Zhou, Min},
title = {An Effective Oral Drug Delivery Route for Pharmacokinetic Complications: Spirulina Lipid Nanotechnology System},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {44},
doi = {10.1002/advs.202509731}
}
EUVIMED